IFITM1 promotes the metastasis of human colorectal cancer via CAV-1

被引:72
|
作者
Yu, Fang [1 ]
Xie, Dan [2 ]
Ng, Samuel S. [3 ]
Lum, Ching Tung [3 ]
Cai, Mu-Yan [4 ]
Cheung, William K. [3 ]
Kung, Hsiang-Fu [5 ,6 ]
Lin, Guimiao [7 ]
Wang, Xiaomei [7 ]
Lin, Marie C. [7 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310027, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou, Guangdong, Peoples R China
[3] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[5] Kunming Med Univ, HK Acad Workstat, Kunming, Peoples R China
[6] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China
[7] Shenzhen Univ, Sch Med, Shenzhen Key Lab Translat Med Tumor, Shenzhen, Peoples R China
关键词
IFITM1; Colorectal cancer; Metastasis; CAV1; INDUCED TRANSMEMBRANE PROTEIN-1; EXPRESSION SUPPRESSES GROWTH; SQUAMOUS-CELL CARCINOMA; GASTRIC-CANCER; BETA-CATENIN; CAVEOLIN-1; TUMORIGENESIS; FAMILY; ACTIVATION; PROLIFERATION;
D O I
10.1016/j.canlet.2015.07.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interferon-induced transmembrane protein 1 (IFITM1) is one of the interferon-induced transmembrane protein family members. In this study, we reported that the elevated IFITM1 expression in human colorectal cancer (CRC) significantly correlated with CRC lymph node and distance metastasis as well as a more advanced clinical stage. Importantly, elevated IFITM1 expression is an independent prognostic factor for poor survival. To investigate the molecular mechanisms, we showed that over-expression of IFITM1 in CRC cells promoted, whereas knockdown of IFITM1 expression inhibited, cell migration/invasion and tumorigenicity in Vitro. Furthermore, we identified Caveolin-1 (CAV1) as a downstream target of IFITM1-induced cell invasion, as knockdown of CAV1 abrogated siIFITM1 mediated inhibition of cell invasion in CRC cells. In addition, in a CRC cohort of 229 patients, the expression of IFITM1 inversely correlated with the expression of CAV1. These results suggested that IFITM1 promotes the aggressiveness of CRC cells, and it is a potential prognostic marker and therapeutic target for CRC. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 50 条
  • [21] CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1
    Weiyu Zhang
    Siyu Chen
    Qiu Du
    Piaopiao Bian
    Yutong Chen
    Zexian Liu
    Jian Zheng
    Ke Sai
    Yonggao Mou
    Zhongping Chen
    Xiang Fan
    Xiaobing Jiang
    Oncogene, 2022, 41 : 1550 - 1562
  • [22] Topology, Antiviral Functional Residues and Mechanism of IFITM1
    Sun, Fang
    Xia, Zhiqiang
    Han, Yuewen
    Gao, Minjun
    Wang, Luyao
    Wu, Yingliang
    Sabatier, Jean-Marc
    Miao, Lixia
    Cao, Zhijian
    VIRUSES-BASEL, 2020, 12 (03):
  • [23] Expression of IFITM1 in chronic myeloid leukemia patients
    Akyerli, CB
    Beksac, M
    Holko, M
    Frevel, M
    Dalva, K
    Özbek, U
    Soydan, E
    Özcan, M
    Özet, GL
    Ilhan, O
    Gürman, G
    Akan, H
    Williams, BRG
    Özçelik, T
    LEUKEMIA RESEARCH, 2005, 29 (03) : 283 - 286
  • [24] LY6K promotes glioblastoma tumorigenicity via CAV-1 mediated ERK1/2 signaling enhancement
    Sastry, Namratha G.
    Wan, Xuechao
    Huang, Tianzhi
    Alvarez, Angel A.
    Pangeni, Rajendra P.
    Song, Xiao
    James, Charles David
    Horbinski, Craig M.
    Brennan, Cameron W.
    Nakano, Ichiro
    Hu, Bo
    Cheng, Shi-Yuan
    NEURO-ONCOLOGY, 2020, 22 (09) : 1315 - 1326
  • [25] The clinical relevance of targeting IFITM1 in three distinct subtypes of aggressive breast cancer
    Lui, Asona
    Ogony, Joshua
    Marquess, Jordan
    Geanes, Eric
    Jewell, William
    El Ayachi, Ikbale
    Miranda-Carboni, Gustav
    Tawfik, Ossama
    Lewis-Wambi, Joan
    CANCER RESEARCH, 2017, 77
  • [26] A Sorting Signal Suppresses IFITM1 Restriction of Viral Entry
    Li, Kun
    Jia, Rui
    Li, Minghua
    Zheng, Yi-Min
    Miao, Chunhui
    Yao, Yunfang
    Ji, Hong-Long
    Geng, Yunqi
    Qiao, Wentao
    Albritton, Lorraine M.
    Liang, Chen
    Liu, Shan-Lu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (07) : 4248 - 4259
  • [27] Overexpression of IFITM1 Has Clinicopathologic Effects on Gastric Cancer and Is Regulated by an Epigenetic Mechanism
    Lee, Jieun
    Goh, Sung-Ho
    Song, Naaleum
    Hwang, Jung-Ah
    Nam, Seungyoon
    Choi, Il Ju
    Shin, Aesun
    Kim, In-Hoo
    Ju, Mi-Ha
    Jeong, Jin Sook
    Lee, Yeon-Su
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (01): : 43 - 52
  • [28] Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
    Wu, Chenlu
    Ying, Jiafei
    Dai, Mei
    Peng, Jing
    Zhang, Danhua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) : 3385 - 3398
  • [29] Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer
    Kim, Nam Hee
    Sung, Hye Youn
    Choi, Eun Nam
    Lyu, Dahyun
    Choi, Hyuck Jae
    Ju, Woong
    Ahn, Jung-Hyuck
    ONCOLOGY REPORTS, 2014, 31 (05) : 2139 - 2146
  • [30] CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation
    Zhao, Guang-Xi
    Xu, Ying-Ying
    Weng, Shu-Qiang
    Zhang, Si
    Chen, Ying
    Shen, Xi-Zhong
    Dong, Ling
    Chen, She
    ONCOGENE, 2019, 38 (23) : 4574 - 4589